🈹🈹🈹Trump has struck again, drug tariffs are coming soon!
1. What is a tariff? Let’s use an analogy 🌰
• Simply put: it's like asking someone in India to buy you cheap medicine, and suddenly Trump says, “You have to pay a 25-dollar toll to enter the U.S!”
• Result: The price of the medicine goes from 100 dollars to 125 dollars, and Americans either have to pay more or can’t buy it at all.
2. Who is hit hardest? India and Switzerland are devastated.
• India: The largest producer of generic drugs (cheap versions of patented drugs) in the world; 70% of America's generic drugs are imported from India. With the new tariffs, orders from Indian drug manufacturers are cut in half.
• Switzerland: Top pharmaceutical companies like Novartis and Roche face tariffs on cancer and diabetes drugs, causing a dramatic increase in costs for U.S. hospitals.
3. Why do Americans suffer too?
• Soaring drug prices: Insulin and cancer drugs could rise by 30%, and chronic illness patients may spend hundreds of extra dollars each month.
• Playing tricks: Trump says “If drug companies move to America, they’ll be tax-exempt,” but building factories takes 3-5 years, so it won’t help in the short term.
4. Trump’s true calculations 🧮
• Shifting blame: The U.S. can’t manage its own drug abuse problem and is shifting the blame to “foreign drugs being too cheap.”
• Gaining votes: Workers in the Midwest “Rust Belt” believe “Trump is helping us get jobs,” but in reality, drug companies won’t return.
• Suppressing competitors: Generic drugs from China and India threaten the profits of American pharmaceutical companies, so tariffs are used to protect domestic giants.
5. What should ordinary people do? Remember these 3 points:
1️⃣ Stock up on medicines: Chinese Americans in the U.S. should quickly stockpile chronic illness medications; they may be out of stock or expensive starting in April.
2️⃣ Beware of counterfeit drugs: The black market may see inferior generic drugs; taking the wrong medication is scarier than price increases.
3️⃣ The costs will be passed on: Pharmaceutical companies won’t lose; ultimately, price increases will burden insurance and patients.
In summary: Trump’s actions are causing Indian drug manufacturers to cry, American patients to suffer, while only pharmaceutical shareholders are laughing slyly. 😏